Indication
Alexander Disease
1 clinical trial
2 products
Clinical trial
A Phase 1-3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered Zilganersen (ION373) in Patients With Alexander DiseaseStatus: Recruiting, Estimated PCD: 2025-03-01
Product
PlaceboProduct
zilganersen